5th iPSC Drug Development Summit
The 5th iPSC Drug Development Summit serves as a pivotal platform for uniting iPSC-based drug developers across the value chain, from research and development through to CMC, to accelerate the development of genetically stable, clinically efficacious, and scalable iPSC cell therapies.
Attendees will have the opportunity to tailor their learning across two dedicated tracks: Preclinical Development and Process Development & CMC. The Preclinical stream will delve into novel humanized mouse models to facilitate a greater translational leap into the clinic, while the Process Development & CMC stream will explore innovative bioreactors and new methods of iPSC generation.
The summit boasts a world-class speaker faculty, featuring experts from leading organizations such as Novo Nordisk, Century Therapeutics, BlueRock Therapeutics, Aspen Neuroscience, Sana Biotech, and GC Therapeutics. These trailblazers will share practical strategies for engineering allo-evasive cell products, overcoming reprogramming and scalability challenges, and addressing regulatory complexities from R&D through to commercialization.
Learn more about the agenda and speakers here: https://ter.li/nr2gtl
This year, the summit will cover a broad range of therapeutic areas, including oncology, neurology, and regenerative medicine. Featured sessions will explore next-generation reprogramming technologies, iPSC cell line selection, advancing GMP-compliant manufacturing and strategies to reduce donor and process variability. The full program is shaped by the field’s most experienced voices and designed to support the translation of early-stage research into commercially viable cell therapies.
With its sharp focus on overcoming translational bottlenecks and ensuring clinical success, the iPSC Drug Development & Manufacturing Summit remains the go-to forum for advancing iPSC science into real-world therapies. You’ll connect with leading developers, regulators, and solution providers to exchange data, discuss lessons learned, and align on best practices that are pushing the field forward.
Join the Cell Therapy Community Here: https://ter.li/7fyy7w
